Former President Donald Trump has hinted at a major shift in federal drug policy, saying he's considering reclassifying marijuana as a less dangerous substance. This comes amid growing pressure following the DEA’s 2024 proposal to move cannabis from Schedule I to Schedule III — a move that would recognize its medical use and significantly ease federal restrictions. However, the rule change has been stalled since March 2025, leaving advocates and industry leaders in limbo. Could Trump's stance reignite federal reform and reshape the future of cannabis in America? Here's what we know so far.
No comments:
Post a Comment